These processing steps convert the transcript into the capped and polyadenylated form used for cellular translation. They are performed after or during in vitro transcription, depending on the preparation strategy, and precede purification. The resulting RNA can then support transient production of Cas9 after delivery into cells with a compatible guide RNA.
Cas9 mRNA provides the temporary instructions for producing the Cas9 enzyme, but the guide RNA directs where the resulting enzyme acts. Together, they enable a targeted DNA break rather than an untargeted editing event. Cellular repair of that break can then produce gene disruption or sequence modification at the selected genomic location.
Because the delivered material is messenger RNA, Cas9 production is transient rather than sustained by continued expression from a genetic template. This limits the duration of enzyme availability in cells while still allowing a targeted DNA break and subsequent repair. The feature is useful when experiments aim to reduce prolonged Cas9 activity during genome editing.
A typical workflow begins with a DNA template containing the Cas9 coding sequence and uses in vitro transcription to generate the RNA. The transcript then receives or incorporates a 5′ cap and poly(A) tail, followed by purification. Purification removes the DNA template, enzymes, and abnormal RNA products before the material is used for cell delivery.
Purification is intended to remove residual DNA template, transcription enzymes, and abnormal RNA products generated during synthesis. Removing these components produces a cleaner preparation for delivery into cells and helps ensure that the material used in a CRISPR experiment is primarily the intended Cas9 transcript rather than a mixture of reaction components.
The prepared transcript supports CRISPR experiments in which transient Cas9 production creates a targeted DNA break for cellular repair. Its applications include gene disruption, sequence modification, functional genomics, disease modeling, and potential therapeutic development. These uses connect RNA preparation quality directly to experiments that investigate gene function or model genetically relevant changes.